How has been the historical performance of Sunil Healthcare?
Sunil Healthcare has experienced a declining trend in net sales and profitability, with net sales dropping from 119.16 Cr in Mar'22 to 83.42 Cr in Mar'25 and a reported net loss of -1.42 Cr in Mar'25. Despite a positive cash flow from operating activities of 11.00 Cr in Mar'25, the company faces increasing liabilities and ongoing financial challenges.
Answer:The historical performance of Sunil Healthcare shows a declining trend in net sales and profitability over the past few years, with a net loss reported in the latest fiscal year.Breakdown:
Sunil Healthcare's net sales have decreased from 119.16 Cr in Mar'22 to 83.42 Cr in Mar'25, reflecting a consistent decline over the years. The total operating income followed a similar trend, dropping from 110.49 Cr in Mar'23 to 83.42 Cr in Mar'25. The company's operating profit (PBDIT) saw fluctuations, peaking at 20.66 Cr in Mar'23 but falling to 11.60 Cr in Mar'25. However, the profit before tax has remained negative since Mar'20, with the latest figure at -1.22 Cr in Mar'25. Consequently, the profit after tax also remained negative, reported at -1.42 Cr in Mar'25, although it improved from -1.79 Cr in Mar'24. The company's total liabilities increased from 120.79 Cr in Mar'23 to 161.94 Cr in Mar'25, while total assets rose from 120.79 Cr to 161.94 Cr in the same period, indicating a growing financial burden. Cash flow from operating activities showed a positive trend in Mar'25 at 11.00 Cr, contrasting with the negative cash flow reported in the previous year. Overall, Sunil Healthcare's financial performance indicates challenges in maintaining sales and profitability, alongside increasing liabilities.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
